Regenxbio FDA Hold, Sanofi Vaccine Demand Softness, and CMS Negotiation Expansion – This Week in Biotech #87

from Biotech Blueprint · host Katerina Roznik

FDA pauses two AAV programs, Sanofi reports US vaccine uptake slipping, and CMS widens negotiations to more blockbuster drugs (Jan 23-29, 2026).Subscribe to Biotech Blueprint at biotechblueprint.com.

Episode metadata supplied by the publisher feed · Published Jan 30, 2026

Embed this episode

Attribution link and audio player

Ready to play

Regenxbio FDA Hold, Sanofi Vaccine Demand Softness, and CMS Negotiation Expansion – This Week in Biotech #87

0:00 7:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biotech Blueprint?

This episode is 7 minutes long.

When was this Biotech Blueprint episode published?

This episode was published on January 30, 2026.

Can I download this Biotech Blueprint episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!